\
&
Contact us
\
&
Contact us
Published on | 4 years ago
Programmes Missions New European Bauhaus Horizon Europe JRC Green DealThe New European Bauhaus Initiative was officially launched by the European Commission on 18 January 2021. It aims to bring the European Green Deal closer to the people based on three core values: sustainability, accessibility and aesthetics. The initiative will be a creative and interdisciplinary space where architects, artists, students, scientists, engineers and designers can collaborate which each other in order to turn this vision into reality.
The New European Bauhaus will unfold in three phases: Design, Delivery and Dissemination.
The European Commission will organise a series of online info sessions where the European Bauhaus Team will present this new initiative and the opportunities to contribute to this Bauhaus initiative. The full schedule of the online info sessions can be found here or on our events page. The first one is planned for 15 February and can be followed by livestream.
To learn more on this initiative, you can also visit the New European Bauhaus website or have a quick look at this Two Page Note - ‘New European Bauhaus explained'.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
